Dignity Health, Mercy Medical Center, Redding, CA, USA.
Section of Thoracic Surgery, University of California Davis, Sacramento, CA, USA.
Surg Endosc. 2018 Jan;32(1):405-412. doi: 10.1007/s00464-017-5696-5. Epub 2017 Jun 29.
Magnetic sphincter augmentation (MSA) is a surgical treatment option for patients with gastroesophageal reflux disease (GERD). MSA consistently improves quality of life, maintains freedom from PPIs, and objectively controls GERD. However, up to 24% of patients did not achieve these outcomes. We sought to identify factors predicting outcomes after MSA placement with the aim of refining selection criteria.
We retrospectively analyzed clinical, endoscopic, manometric, pH data, and intraoperative factors from two databases: Pivotal Trial (N = 99) and our prospectively maintained esophageal database (N = 71). A priori outcomes were defined as excellent (GERD-HRQL <5, no PPI, no esophagitis), good (GERD-HRQL 6-15, no PPI, grade A esophagitis), fair (GERD-HRQL 16 to 25, PPI use, grade B esophagitis), and poor (GERD-HRQL >25, PPI use, grade C/D esophagitis). Univariable and multivariable logistic regression analyses were performed to determine predictors of achieving an excellent/good outcome.
A total of 170 patients underwent MSA with a median age of 53 years, [43-60] and a median BMI of 27 (IQR = 24-30). At baseline, 93.5% of patients experienced typical symptoms and 69% atypical symptoms. Median DeMeester score was 37.9 (IQR 27.9-51.2) with a structurally intact sphincter in 47%. Esophagitis occurred in 43%. At 48 [19-60] months after MSA, excellent outcomes were achieved in 47%, good in 28%, fair in 22%, and poor in 3%. Median DeMeester score was 15.6 (IQR = 5.8-26.6), esophagitis in 17.6% and daily PPI use in 17%. At univariable analysis, excellent/good outcomes were negatively impacted by BMI, preoperative LES residual pressure, Hill grade, and hiatal hernia. At multivariable analysis, BMI >35 (OR = 0.05, 0.003-0.78, p = 0.03), structurally defective LES (OR = 0.37, 0.13-0.99, p = 0.05), and preoperative LES residual pressure (OR = 0.89, 0.80-0.98, p = 0.02) were independent negative predictors of excellent/good outcome.
Magnetic sphincter augmentation results in excellent/good outcomes in most patients but a higher BMI, structurally defective sphincter, and elevated LES residual pressure may prevent this goal.
磁括约肌增强术(MSA)是胃食管反流病(GERD)患者的一种手术治疗选择。MSA 始终能改善生活质量,保持 PPI 停药,并客观控制 GERD。然而,多达 24%的患者无法达到这些结果。我们旨在确定预测 MSA 放置后结果的因素,以完善选择标准。
我们回顾性分析了来自两个数据库的临床、内镜、测压和 pH 数据以及术中因素:关键试验(N=99)和我们前瞻性维护的食管数据库(N=71)。预先设定的结果定义为优秀(GERD-HRQL<5,无 PPI,无食管炎)、良好(GERD-HRQL6-15,无 PPI,A级食管炎)、中等(GERD-HRQL16 至 25,使用 PPI,B 级食管炎)和差(GERD-HRQL>25,使用 PPI,C/D 级食管炎)。进行单变量和多变量逻辑回归分析,以确定实现优秀/良好结果的预测因素。
共有 170 名患者接受了 MSA 治疗,中位年龄为 53 岁[43-60],中位 BMI 为 27(IQR=24-30)。基线时,93.5%的患者有典型症状,69%的患者有非典型症状。中位 DeMeester 评分 37.9(IQR 27.9-51.2),47%的患者括约肌结构完整。食管炎发生率为 43%。MSA 后 48[19-60]个月,优秀结果为 47%,良好为 28%,中等为 22%,差为 3%。中位 DeMeester 评分 15.6(IQR=5.8-26.6),食管炎发生率为 17.6%,每日 PPI 使用发生率为 17%。单变量分析显示,BMI、术前 LES 残余压力、Hill 分级和食管裂孔疝与优秀/良好结果呈负相关。多变量分析显示,BMI>35(OR=0.05,0.003-0.78,p=0.03)、LES 结构缺陷(OR=0.37,0.13-0.99,p=0.05)和术前 LES 残余压力(OR=0.89,0.80-0.98,p=0.02)是优秀/良好结果的独立负预测因素。
磁括约肌增强术在大多数患者中可获得优秀/良好的结果,但较高的 BMI、结构缺陷的括约肌和升高的 LES 残余压力可能会阻止达到这一目标。